📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

A combined oral contraceptive containing 30 mcg ethinyl estradiol and 3.0 mg drospirenone does not impair endothelium-dependent vasodilation. (2010)

First Author: Meendering JR

Attributed to: In vivo and in vitro studies of dietary fatty acids eNOS polymorphisms and insulin resistance in the endothelium funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.contraception.2010.03.009

PubMed Identifier: 20851231

Publication URI: http://europepmc.org/abstract/MED/20851231

Type: Journal Article/Review

Volume: 82

Parent Publication: Contraception

Issue: 4

ISSN: 0010-7824